CCL2 and depressive symptom measurement: Also, there was no significant difference in the proportion of patients with anxiety (HADS-A ≥ 8) and depression (HADS-D ≥ 8) between Q1 and Q4 of IL-1β, IL-2, IL-6, IFN-γ, and CCL2.